2-Amino-N-pyrimidin-4-ylacetamides as A2AReceptor Antagonists: 1. Structure−Activity Relationships and Optimization of Heterocyclic Substituents
Citations Over TimeTop 12% of 2008 papers
Abstract
Previously we have described a novel series of potent and selective A 2A receptor antagonists (e.g., 1) with excellent aqueous solubility. While these compounds are efficacious A 2A antagonists in vivo, the presence of an unsubstituted furyl moiety was a cause of some concern. In order to avoid the potential metabolic liabilities that could arise from an unsubstituted furyl moiety, an optimization effort was undertaken with the aim of replacing the unsubstituted furan with a more metabolically stable group while maintaining potency and selectivity. Herein, we describe the synthesis and SAR of a range of novel heterocyclic systems and the successful identification of a replacement for the unsubstituted furan moiety with a methylfuran or thiazole moiety while maintaining potency and selectivity.
Related Papers
- → Design, synthesis, and structure–activity relationship of novel CCR2 antagonists(2008)25 cited
- → Synthesis and SAR studies of a novel class of S1P1 receptor antagonists(2007)14 cited
- → Quantitative Structure-Activity Relationships of 5-Lipoxygenase Inhibitors. Inhibitory Potency of Pyridazinone Analogues(1994)13 cited
- → Synthesis and structure–activity relationships of N-substituted spiropiperidines as nociceptin receptor ligands: Part 2(2008)11 cited
- → New nonpeptide angiostensin II receptor antagonists. Synthesis, biological properties and structure-activity relationships of 3-substituted 2,6-dialkyl-4-(biphenyll)methylaminopyridine derivatives.(1994)1 cited